An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
Read more https://www.sciencedaily.com/releases/2024/05/240517111457.htm
An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
Read more https://www.sciencedaily.com/releases/2024/05/240517111457.htm